miR-451 has also been shown to reduce angiogenesis in colorectal cancer cells by targeting the interleukin – 6 receptor (IL-6R) [16] and to decrease T-cell responses to infection by inhibiting the expression of the regulatory gene, myc [17]. Here, IL6R is linked to colorectal cancer.